Alembic Pharma Q1 PAT may dip 16.70% YoY to Rs 86.3 cr: KR Choksey

KR Choksey has come out with its first quarter (April-June) earnings estimates for the Pharma sector. The brokerage house expects Alembic Pharma to report net profit at 86.3 crore down 16.70% year-on-year (9.54% quarter-on-quarter).

Net Sales are expected to decrease by 6.86 percent Q-o-Q (down 6.29 percent Y-o-Y) to Rs 689.5 crore, according to KR Choksey.

Earnings before interest, tax, depreciation and amortisation (EBITDA) are likely to fall by 6.68 percent Q-o-Q (down 19.94 percent Y-o-Y) to Rs 125.7 crore.

Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.